Drug Type Small molecule drug |
Synonyms Amlodipine/bisoprolol, Bisoprolol/amlodipine, Concor-AM + [3] |
Action blockers, antagonists |
Mechanism L-type calcium channel blockers(Voltage-gated L-type calcium channel blockers), VDCCs blockers(Voltage-gated calcium channel blockers), β1-adrenergic receptor antagonists(Beta-1 adrenergic receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date India (01 Jan 2010), |
Regulation- |
Molecular FormulaC22H35NO8 |
InChIKeyRZPZLFIUFMNCLY-WLHGVMLRSA-N |
CAS Registry104344-23-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypertension | China | 11 May 2021 | |
Essential Hypertension | India | 01 Jan 2010 |
Phase 3 | 200 | (Amlodipine Failed Group) | ibhglovqjb(oeafvvxfsd) = sxfmjmxqnd aozddcyqey (eavozfxubv, 8.21) View more | - | 11 Aug 2016 | ||
(Bisoprolol Failed Group) | ibhglovqjb(oeafvvxfsd) = hefshfmuxp aozddcyqey (eavozfxubv, 11.57) View more |